Skip to main content

Emergent BioSolutions to Manufacture Another COVID-19 Vaccine Candidate

Emergent BioSolutions Inc. has received $135M in funding from Johnson & Johnson that will support large-scale manufacturing of J&J’s lead COVID-19 vaccine candidate at their Baltimore City-based manufacturing facility. "Emergent could make up to 300 million doses to advance the vaccine candidate," said Syed Husain, senior vice president, according to the


Read More

 
Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927